Brizel, David M <br/><br/>
Targeting the future in head and neck cancer.  [electronic resource] 

 -  The Lancet. Oncology  Mar 2009 
 - 204-5 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(09)70051-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab<br/>Carcinoma, Squamous Cell--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Quinazolines--administration & dosage<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors